scleroderma. Systemic sclerosis [scleroderma]
Conditions
Interventions
Intervention 1: Intervention group: Patients will undergo a single injection of 5 cc of SVF cells (20 million cells) at the lesion site. Intervention 2: Control group: Patients will undergo a single i
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The patient is suffering from scleroderma and has been diagnosed by a doctor. The patient has skin involvement in the fingers or face. The patient is in the stable phase of the disease, which is confirmed by the attending physician. The patient has the desire to perform the mentioned procedure.
Exclusion criteria
Exclusion criteria: having infectious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qualitative intensity of scleroderma. Timepoint: Before treatment and 3 months after treatment. Method of measurement: Patient complaint, objective evaluation by a physician. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantitative intensity of scleroderma. Timepoint: Before treatment, three months after treatmen. Method of measurement: Determine the size of the lesions with visioface, determine the location and number of lesions.;The rate of improvement of scleroderma. Timepoint: Before treatment, three months after treatment. Method of measurement: Patient satisfaction, visioface photography, physician diagnosis.;Adverse events. Timepoint: Before treatment, three months after treatment. Method of measurement: Patient report, Physician diagnosis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed